Premium
A double‐blind, placebo‐controlled trial of topical 1,25‐dihydroxycholecalciferol in psoriasis
Author(s) -
HENDERSON C.A.,
PAPWORTHSMITH J.,
CUNLIFFE W.J.,
HIGHET A.S.,
SHAMY H.K.,
CZARNETZKI B.M.
Publication year - 1989
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1989.tb15517.x
Subject(s) - psoriasis , placebo , double blind , medicine , dermatology , double blind study , pathology , alternative medicine
SUMMARY In a double‐blind trial of topical 1,25‐dihydroxycholecalciferol in 47 patients with psoriasis no benefit was shown compared with placebo.